International Journal of Hypertension / 2020 / Article / Tab 2

Research Article

Characterizing Patients with Uncontrolled Blood Pressure at an Urban Hospital in Hanoi, Vietnam

Table 2

Clinical characteristics of hypertensive patients.

CharacteristicsControlled hypertensionUncontrolled hypertensionTotalp
n%n%n%

Comorbidities
Cardiac diseases3963.92236.16127.70.41
Stroke571.4228.673.20.52
Cerebrovascular diseases770.0330.0104.60.49
Vascular diseases1976.0624.02511.40.08
Kidney diseases/failure952.9847.1177.70.56
Metabolic syndrome1238.71961.33114.10.01
Blood lipid disorders5662.23437.89040.90.50
Digestive diseases2877.8822.23616.40.02
Diabetes2653.12346.94922.30.29
Cancer150.0150.020.90.78
Spine/joint pain5764.03236.08940.50.26
Liver diseases940.91359.12210.00.06
Prostate diseases770.0330.0104.60.49
Vestibular diseases583.3116.762.70.23

Duration of disease (years)
1– < 2 years2956.92243.15123.20.50
2–5 years4265.62234.46429.1
>5 years6057.14542.910547.7
Number of antihypertensive drugs used
12161.81338.23415.50.77
≥211059.17640.918684.6

Overweight/obesity
No5964.83235.29141.40.18
Yes7255.85744.212958.6
MedianIQRMedianIQRMedianIQRp
Duration of disease (years)5[3–10]6[2.2–10]5[3–10]0.56
Number of comorbidities2[1–3]2[1–3]2[1–3]0.72
Body mass index (kg/m2)23.4[21.8–25.2]24.0[22.3–26.1]23.7[21.9–25.4]0.02
Last low-density lipoprotein (LDL, mmol/L)2.5[1.4–3.3]2.3[1.3–3.2]2.5[1.4–3.3]0.67
Last high-density lipoprotein (HDL, mmol/L)1.3[1.1–1.6]1.2[1.1–1.4]1.2[1.1–1.6]0.18
Last triglyceride (mmol/L)1.8[1.4–2.4]2.0[1.3–2.9]1.9[1.4–2.8]0.35

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.